Data Hub

Bridging the gap between in vitro and in vivo.

Publications, case studies and webinars showing how researchers use TROVO to move beyond marker dependency and noisy bulk readouts.

Featured publication

Nanobody MET CAR-T cells show efficacy in solid tumors

Katz Lab, Yale University — Preprint, January 2026. Chen PH, Li Q, Deveraux S, Sohai D, Cha PC, Raghunandan R, Chen N, Li Y, Nguyen M, Stankewich MC, Morrow JS, Augert A, Yan QC, Katz SG.

The study evaluated MET-targeting VHH CAR-T cells as an alternative to conventional scFv-based CAR-T constructs. TROVO was used to evaluate hydrogel microwell-based cellular kinetics and track real-time cytotoxicity across thousands of individual co-cultures.

Intermediate avidity wins

Intermediate-avidity clones outperformed high-avidity clones in vitro — a finding enabled by per-clone kinetic tracking.

Low tonic signaling

VHH-CAR-T cells showed superior biochemical stability and favorable cytokine profiles vs traditional scFv-based designs.

Functional kinetics at scale

TROVO microwell co-cultures enabled direct measurement of cytotoxicity and T cell behavior across thousands of interactions.

Proven in TNBC models

VHH-CAR-T cells demonstrated potent and prolonged tumor growth control in metastatic triple-negative breast cancer models.

Case studies

Real workflows, from clinical sample to functional clone.

Immunotherapy

TIL Potency Assessment

Distinguishing responders from non-responders

TROVO seeds patient TILs and tumor cells into thousands of microwells, tracks killing longitudinally and compares each co-culture against matched tumor-only controls — enabling statistically rigorous responder discrimination from scarce clinical samples.

Manufacturing

Full TIL Discovery Workflow

From tissue to functional clone recovery

Dissociate → seed → image (2–5 days) → rank by Z-score → capture → wash → enzymatic release → NGS / expansion / re-challenge. A clinical-manufacturing-compatible, function-first workflow with intact transcriptome after recovery.

CAR-T / TCR-T

Clone Selection Based on Co-Cultures

12-day persistence assays with tumor re-challenge

TROVO tracks cytotoxicity and persistence kinetics over 12 days with tumor re-challenge every three days, ranking clones by functional Z-score and capturing viable populations for downstream NGS and expansion.

Kinetic modeling

Predator–Prey Kinetics

Intrinsic vs cooperative tumor killing

Per-clone data fit to Lotka–Volterra equations yields clone-specific killing rate constants, separating intrinsic killing capacity from cooperative wolf-pack killing — with in vivo correlation in NSG mouse models.

Antibody discovery

B Cell Screening for Native Protein Binding

Two-round multi-signal workflow

Identify B cells that bind both target peptide and full-length native protein — from PBMC seeding and streptavidin bead coating through photo-crosslinked capture, wash and enzymatic release for RT-PCR and Sanger sequencing.

Single-cell omics

Live Cell Enrichment for scRNA-seq

Image-guided, fluidics-free tissue processing

From raw tissue to single-cell suspension in ~4 hours for three samples, using only ~10⁴ cells. No clogging, no shear stress, improved reads-in-cells and preserved tissue-specific features.

On-demand webinars

Watch scientists using TROVO in their own words.

Decoding CAR-T Cell Fitness — Linking CRISPR Screen Hits to Functional Phenotypes

Brandon Simone
Gill Lab, University of Pennsylvania

Not all CRISPR hits are equal. Some edits drive proliferation while others enhance cytotoxicity or persistence. Functional resolution at the single-well level reveals what bulk screens miss.

Request access

Integrated High-Throughput Functional Profiling of Myeloid Cells in Pancreatic Cancer

Dr. Won Jin Ho
Johns Hopkins University

The DEFINE workflow, myeloid heterogeneity, high-plex Imaging Mass Cytometry and TROVO-enabled functional co-culture assays — linking real-time killing kinetics to high-plex proteomic data.

Request access

Functional Selection of CAR-T Clones from 2D and 3D Brain Tumor Co-Cultures

Dr. Xiujian Ma
City of Hope

CAR-T clone selection in 2D and 3D brain tumor co-culture models, including glioblastoma — with AI-driven kinetic analysis supporting scalable CAR-T development workflows.

Request access

Get in touch

Want to see TROVO data specific to your assay?

Our scientific team can share protocols, per-application datasets and application notes tailored to your workflow.